New research in biomechanics measures the impact of head-first, hand-first and feet-first diving and the likelihood of injury at different diving heights.
The “Biomedical Engineering Symposium: Tools to Transform Discovery and Care,” brought together dozens of engineers, scientists and practitioners from across Cornell to share research and foster collaborations, with the goal of building the foundation for new, cutting-edge medical treatments and devices.
A Cornell-led group of researchers has developed an online search method that employs natural language processing to identify terms that are semantically similar to those for cancer screening tests, but in colloquial language.
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia, according to a preclinical study by investigators at Weill Cornell Medicine.
Concern is growing given the sluggish rollout of the coronavirus vaccination distribution in New York. Cynthia Leifer, associate professor of immunology at Cornell University, says vaccines need to be given quickly as possible and rather than disqualifying sites from getting future distributions, expanding the number of distribution locations and incentivizing rapid use is a better solution.
From new approaches for tendon injury treatment to biomass-based construction materials, Cornell Engineering’s inaugural Sprout Awards are funding unique research projects with the potential to grow partnerships across Cornell.
New cancer cell research opens a new avenue for understanding how tumors spread to other tissues via metastasis, and hints at novel ways to block the spread of cancer by targeting the process.
A Cornell-led collaboration used machine learning to pinpoint the most accurate means, and timelines, for anticipating the advancement of Alzheimer’s disease.
Robert J. “Bob” Appel ’53, a vice chair of Weill Cornell Medicine’s Board of Fellows, Cornell trustee emeritus and presidential councillor, died Nov. 19 in New York, at age 91.
A Cornell multidisciplinary research center that studies chronic fatigue syndrome has received a five-year, $9.5 million grant from the National Institutes of Health – funding that will enable experts to continue work on the mysterious and debilitating condition.
